Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001968202-23-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-03 | 2023-05-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $805.33 | -100 | 19.0K | -0.5% | -$80.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | S | D | 2 | $804.51 | 18,999 | D | — | — | (F4) Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2023 at prices ranging from $804.20 to $804.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-05-01 | S | D | 15 | $806.53 | 18,979 | D | — | — | (F6) Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $806.01 to $806.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-05-01 | S | D | 17 | $807.50 | 18,962 | D | — | — | (F7) Represents volume-weighted average price of sales of 17 shares of Company stock on May 1, 2023 at prices ranging from $807.12 to $807.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-05-01 | S | D | 15 | $808.11 | 18,947 | D | — | — | (F8) Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $808.00 to $808.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-05-01 | S | D | 30 | $803.58 | 19,001 | D | — | — | (F3) Represents volume-weighted average price of sales of 30 shares of Company stock on May 1, 2023 at prices ranging from $803.22 to $803.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-05-01 | S | D | 16 | $802.67 | 19,031 | D | — | — | (F2) Represents volume-weighted average price of sales of 16 shares of Company stock on May 1, 2023 at prices ranging from $802.57 to $802.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-05-01 | S | D | 5 | $805.34 | 18,994 | D | — | — | (F5) Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2023 at prices ranging from $805.22 to $805.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price. |